Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Schools, Public Health | 1 | 2018 | 10 | 0.75 | Why? |
| HIV Infections | 10 | 2021 | 11620 | 0.68 | Why? |
| Budgets | 1 | 2018 | 155 | 0.62 | Why? |
| Administrative Personnel | 1 | 2018 | 326 | 0.57 | Why? |
| HIV Seropositivity | 1 | 2017 | 320 | 0.56 | Why? |
| Patient Protection and Affordable Care Act | 1 | 2017 | 164 | 0.56 | Why? |
| Policy Making | 2 | 2018 | 829 | 0.54 | Why? |
| Health Policy | 3 | 2018 | 6242 | 0.51 | Why? |
| Cost-Benefit Analysis | 6 | 2021 | 2259 | 0.49 | Why? |
| Program Evaluation | 2 | 2019 | 1929 | 0.47 | Why? |
| Health Services Research | 1 | 2018 | 756 | 0.47 | Why? |
| Faculty, Medical | 1 | 2018 | 595 | 0.46 | Why? |
| Continuity of Patient Care | 2 | 2019 | 1574 | 0.46 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 533 | 0.42 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.42 | Why? |
| Pre-Exposure Prophylaxis | 1 | 2019 | 1138 | 0.40 | Why? |
| Health Equity | 1 | 2021 | 1223 | 0.38 | Why? |
| Epidemics | 4 | 2021 | 6407 | 0.38 | Why? |
| Attitude | 1 | 2018 | 1481 | 0.37 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.36 | Why? |
| Guidelines as Topic | 1 | 2021 | 2844 | 0.35 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.34 | Why? |
| Health Status Disparities | 3 | 2020 | 4072 | 0.34 | Why? |
| AIDS Serodiagnosis | 2 | 2017 | 64 | 0.32 | Why? |
| United States | 12 | 2021 | 46150 | 0.31 | Why? |
| Health Care Costs | 3 | 2018 | 1007 | 0.29 | Why? |
| Goals | 2 | 2019 | 335 | 0.28 | Why? |
| Quality-Adjusted Life Years | 2 | 2018 | 511 | 0.28 | Why? |
| New York | 6 | 2021 | 2488 | 0.27 | Why? |
| Politics | 1 | 2017 | 1824 | 0.25 | Why? |
| Health Care Rationing | 1 | 2018 | 2558 | 0.25 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.23 | Why? |
| HIV Seronegativity | 1 | 2019 | 112 | 0.19 | Why? |
| Public Health Systems Research | 1 | 2018 | 6 | 0.19 | Why? |
| Smoking Prevention | 1 | 2018 | 116 | 0.17 | Why? |
| Financing, Organized | 1 | 2018 | 137 | 0.16 | Why? |
| Hospitalization | 5 | 2021 | 54280 | 0.15 | Why? |
| Evidence-Based Medicine | 2 | 2019 | 3228 | 0.15 | Why? |
| Anti-HIV Agents | 2 | 2018 | 2209 | 0.14 | Why? |
| Organizational Culture | 1 | 2018 | 395 | 0.14 | Why? |
| Cost Savings | 1 | 2017 | 296 | 0.14 | Why? |
| Sexual Partners | 1 | 2019 | 612 | 0.14 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.13 | Why? |
| Incidence | 4 | 2020 | 25622 | 0.13 | Why? |
| HIV | 1 | 2020 | 1116 | 0.13 | Why? |
| Risk Reduction Behavior | 1 | 2019 | 946 | 0.12 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.11 | Why? |
| Rural Health Services | 1 | 2018 | 496 | 0.11 | Why? |
| Health Expenditures | 1 | 2018 | 904 | 0.10 | Why? |
| Interpersonal Relations | 1 | 2018 | 926 | 0.10 | Why? |
| Learning | 1 | 2018 | 1181 | 0.10 | Why? |
| Humans | 24 | 2021 | 930598 | 0.10 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.10 | Why? |
| Health Priorities | 1 | 2018 | 959 | 0.10 | Why? |
| Community Health Services | 1 | 2018 | 1000 | 0.10 | Why? |
| Government | 1 | 2018 | 1453 | 0.09 | Why? |
| Social Stigma | 1 | 2018 | 1049 | 0.09 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.09 | Why? |
| Azithromycin | 2 | 2020 | 3943 | 0.09 | Why? |
| Prevalence | 3 | 2020 | 25773 | 0.09 | Why? |
| Sexual and Gender Minorities | 1 | 2018 | 1019 | 0.09 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.09 | Why? |
| Health Services Accessibility | 3 | 2018 | 10697 | 0.09 | Why? |
| Motivation | 1 | 2018 | 1640 | 0.09 | Why? |
| African Americans | 2 | 2021 | 3363 | 0.08 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.08 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.08 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.07 | Why? |
| Health Promotion | 1 | 2018 | 2020 | 0.07 | Why? |
| Decision Making | 1 | 2018 | 3132 | 0.07 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2009 | 952 | 0.06 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.06 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.05 | Why? |
| Clinical Laboratory Techniques | 3 | 2021 | 23402 | 0.05 | Why? |
| Models, Theoretical | 1 | 2018 | 6659 | 0.05 | Why? |
| Medication Adherence | 1 | 2009 | 1270 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Safe Sex | 1 | 2019 | 135 | 0.05 | Why? |
| Homosexuality | 1 | 2018 | 16 | 0.05 | Why? |
| Alabama | 1 | 2018 | 72 | 0.05 | Why? |
| Heterosexuality | 1 | 2019 | 148 | 0.05 | Why? |
| Condoms | 1 | 2019 | 235 | 0.04 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Homeless Persons | 1 | 2009 | 1171 | 0.04 | Why? |
| Adult | 9 | 2021 | 244371 | 0.04 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.04 | Why? |
| Adolescent | 7 | 2021 | 86841 | 0.04 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.04 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.04 | Why? |
| Gender Identity | 1 | 2018 | 262 | 0.04 | Why? |
| Spatial Analysis | 1 | 2020 | 878 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2019 | 694 | 0.03 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.03 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Heart Arrest | 1 | 2020 | 1239 | 0.02 | Why? |
| Anti-Retroviral Agents | 1 | 2018 | 1099 | 0.02 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.02 | Why? |
| Male | 8 | 2021 | 367725 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2020 | 6543 | 0.02 | Why? |
| Female | 8 | 2021 | 380317 | 0.02 | Why? |
| New York City | 1 | 2021 | 7432 | 0.02 | Why? |
| Arrhythmias, Cardiac | 1 | 2020 | 2510 | 0.02 | Why? |
| Telemedicine | 1 | 2018 | 25032 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
| Aged | 5 | 2021 | 215776 | 0.02 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.02 | Why? |
| Electronic Health Records | 1 | 2018 | 3492 | 0.02 | Why? |
| Substance Abuse, Intravenous | 1 | 2009 | 411 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Regression Analysis | 1 | 2009 | 2484 | 0.01 | Why? |
| Housing | 1 | 2009 | 1146 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Depressive Disorder | 1 | 2009 | 1236 | 0.01 | Why? |
| Infant | 1 | 2020 | 30274 | 0.01 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Child, Preschool | 1 | 2020 | 36283 | 0.01 | Why? |
| Attitude to Health | 1 | 2009 | 2002 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Mental Health | 1 | 2018 | 15770 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2009 | 53120 | 0.00 | Why? |
| Aged, 80 and over | 1 | 2009 | 88759 | 0.00 | Why? |
Holtgrave's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(129)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_